The price-to-earnings ratio for Globus Medical stock stands at 43.87 as of Jun 4, 2025. This is calculated based on the current EPS of $1.36 and the stock price of $59.66 per share. A decrease of 68% has been recorded in the PE ratio compared to the average of 138.0 of the past four quarters.
Over the last ten years, the average PE ratio of Globus Medical has been 46.68. The current 43.87 price-to-earnings ratio is 6% less than the historical average. In the past ten years, GMED's PE ratio reached its highest point in the Jun 2024 quarter at 273.96, with a price of $68.49 and an EPS of $0.25. The Sep 2016 quarter saw the lowest point at 18.35, with a price of $22.57 and an EPS of $1.23.
Maximum annual increase: 122.6% in 2024
Maximum annual decrease: -26.29% in 2018
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 108.83 | 122.6% | $82.71 | $0.76 |
2023 | 48.89 | 24.4% | $53.29 | $1.09 |
2022 | 39.3 | -19.43% | $74.27 | $1.89 |
2021 | 48.78 | -22.21% | $72.2 | $1.48 |
2020 | 62.71 | 67.23% | $65.22 | $1.04 |
2019 | 37.5 | 38.63% | $58.88 | $1.57 |
2018 | 27.05 | -26.29% | $43.28 | $1.6 |
2017 | 36.7 | 61.25% | $41.1 | $1.12 |
2016 | 22.76 | -2.65% | $24.81 | $1.09 |
2015 | 23.38 | -3.63% | $27.82 | $1.19 |
2014 | 24.26 | -11.04% | $23.77 | $0.98 |
2013 | 27.27 | 113.21% | $20.18 | $0.74 |
2012 | 12.79 | N/A | $10.49 | $0.82 |
2011 | N/A | N/A | N/A | $0.69 |
2010 | N/A | N/A | N/A | $0.61 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 53.82 | -50.55% | $73.2 | $1.36 |
Dec 2024 | 108.83 | -5.69% | $82.71 | $0.76 |
Sep 2024 | 115.39 | -57.88% | $71.54 | $0.62 |
Jun 2024 | 273.96 | 201.32% | $68.49 | $0.25 |
Mar 2024 | 90.92 | 85.97% | $53.64 | $0.59 |
Dec 2023 | 48.89 | 54.62% | $53.29 | $1.09 |
Sep 2023 | 31.62 | 8.32% | $49.65 | $1.57 |
Jun 2023 | 29.19 | 3.58% | $59.54 | $2.04 |
Mar 2023 | 28.18 | -28.3% | $56.64 | $2.01 |
Dec 2022 | 39.3 | 1.6% | $74.27 | $1.89 |
Sep 2022 | 38.68 | 5.42% | $59.57 | $1.54 |
Jun 2022 | 36.69 | -30.38% | $56.14 | $1.53 |
Mar 2022 | 52.7 | 8.04% | $73.78 | $1.4 |
Dec 2021 | 48.78 | 19.06% | $72.2 | $1.48 |
Sep 2021 | 40.97 | -2.24% | $76.62 | $1.87 |
The current PE ratio of GMED is lower than the 3, 5 and 10-year averages.
GMED's PE ratio is below its peer stock SYK.
Stock name | PE ratio | Market cap |
---|---|---|
GMED Globus Medical Inc | 43.87 | $8.08B |
SYK Stryker Corp | 51.01 | $146.2B |
OFIX Orthofix Medical Inc | N/A | $427.07M |
ATEC Alphatec Holdings Inc | N/A | $1.8B |
The price to earnings ratio for GMED stock as of Jun 4, 2025, stands at 43.87.
Over the last 3 years, the average PE ratio for GMED stock is 74.62.
Over the last 5 years, the average PE ratio for GMED stock is 64.86.
In the last ten years, the Jun 2024 quarter recorded the highest quarterly PE ratio at 273.96.
The current price to earnings ratio of GMED is 6% lower than the 10-year historical average.
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Jun 4, 2025), Globus Medical's stock price is $59.66. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $1.36. Therefore, Globus Medical's price to earnings ratio for today is 43.87. PE RATIO(43.87) = STOCK PRICE($59.66) / TTM EPS($1.36)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.